With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
Marine Warfighting Lab Turns Lessons from Ukraine into Future Strategy
The Marine Corps Warfighting Laboratory uses wargaming and simulation to analyze threats, test capabilities and prepare for future conflicts.
12m listen -
Former DOL CISO on the Importance of Building Your Network
Paul Blahusch discusses leveraging your network and the power of pivoting.
7m watch -
VHA Deploys Agentic AI Operating System to Improve Care Delivery
The new agentic AI system connects teams, automates workflows and accelerates decision-making across VA medical centers.
4m read -
Inside DOE’s Genesis Mission to Power AI-Driven Science
Rick Stevens explains how DOE’s Genesis mission is integrating supercomputing, AI and quantum technologies to accelerate scientific discovery.
25m watch
